Skip to main content
Clinical Trials/ISRCTN45616481
ISRCTN45616481
Active, not recruiting
未知

Improving care for patients living with persistent non-cancer pain and taking opioid medicines long-term: a multicentre cluster randomised controlled trial of proactive clinical review led by practice pharmacists in primary care: the PROMPPT trial

Keele University0 sites896 target enrollmentMay 13, 2022

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Keele University
Enrollment
896
Status
Active, not recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
May 13, 2022
End Date
March 31, 2025
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\. Adult patients aged \=18 years
  • 2\. Prescribed any opioid analgesic (defined as any opioid or opioid/paracetamol combination analgesic from sections 4\.7\.2 and 4\.7\.1 British National Formulary \[BNF]) for chronic non\-cancer pain continuously for \=6 months
  • 3\. Prescription issued within the previous 2 months

Exclusion Criteria

  • 1\. Patients being treated for acute pain (self\-limiting pain, for example after injury or surgery), pain associated with cancer and patients with terminal illness (life expectancy \<6 months)
  • 2\. Vulnerable patients (e.g. severe mental illness, learning difficulties, dementia)
  • 3\. Patients currently receiving treatment for substance misuse

Outcomes

Primary Outcomes

Not specified

Similar Trials